Hamp’s Bio IPO GMP: The initial share sale of Hamps Bio Ltd., a company engaged in the marketing and distribution of pharmaceutical products, opened for bidding last week. The SME IPO was booked over 10 times on the opening day on 13 Dec.
Table of Contents
Hamp’s Bio IPO GMP Today
The grey market premium (GMP) of Hamp’s Bio IPO was Rs 51 on 17 December, climbing from Rs 35 when the issue opened for subscription on Friday. The GMP trends have shown an upward trend since the announcement of the IPO price band. The Rs 6.22-crore Hamp’s Bio IPO (initial public offering) is an entirely fresh issue of 12.2 lakh shares.
The Price Band of the Hamp’s Bio IPO GMP
Hamps Bio IPO price band has been fixed at Rs 51 per share, making it a fixed price issue. Retail investors must buy at least 2,000 shares in one lot, taking the minimum investment amount to Rs 1,02,000
- Bigshare Services Pvt. has been appointed as registrar for the Hamps Bio IPO. Marwadi Chandarana Intermediaries Brokers Pvt. is acting as the book-running lead manager of the issue and Pure Broking is its market maker.
Hamp’s Bio IPO GMP Details
- IPO open date. – 13 December
- IPO closing date. – 17 December
- Share allotment. – 18 December
- Credit for demat account. – 19 December
- Refund. – 19 December
- Listed on the share market. – 20 December
- Face value – 10 ru. Per equity share
- Issue size. – 6.22 crore.
About the Company
- The Company was established in 2007.
- Hamps Bio Ltd. distributes pharmaceutical products, including tablets, syrups, capsules, injectables, oil, and nutritional supplements via a network of over 50 distributors and e-commerce platforms.
- Other than Pharma products, they also offer freeze-dried and frozen products such as fruits, vegetables, herbs, and flowers.
- The platforms include Amazon (US, Canada, EU), Flipkart, and Jio Mart.
- The pharma products are sold in 8 states and Union Territories across India. On the other hand, the freeze-dried and frozen products are distributed in six countries as well as 22 states and UTs in India.
- As of the period ended October 31, the company’s revenue from operations was Rs 4.26 crore,
- while its net profit stood at Rs 34.08 lakh. In FY24, Hamps Bio Ltd.
- According to the report the Company’s revenue of Rs 6.47 crore and a net profit of Rs 50.07 lakh.
- The business of the company is done in 2 segments
- Pharma products are sold under the Humps brand.
- Frozen freeze-dried powder of strawberry, jamun, mango, and sapota is sold under the Fzyezy brand.
- Including both segments more than 180 products are available.
Hamps Bio Limited IPODec 13, 2024
— Anuj Jambhulkar (@JambhulkarAnuj) December 13, 2024
= IPO Opening Date: December 13, 2024
= IPO Closing Date: December 17, 2024
= Issue Type: Fixed Price Issue
= Issue Size: rs 6.22 Cr
= Fresh Issue: 1,220,000 equity shares
= Face Value: rs 10 per share
= Issue Price: rs 51 per share
=… pic.twitter.com/YEb2O9658p
Aim of the Hamp’s Bio IPO GMP
Hamps Bio Ltd. will use the net proceeds from the IPO to buy machines and a plant for its FMCG division, as well as increase the brand’s visibility and awareness. Further, some of the proceeds will also be used for general corporate purposes.
Jay Chavda He is the Founder and Writer of businesspulsecare.com. He is an I.T Engineer, Freelancer, Businessman. He posts Business, Stock/Share Market, Finance Related News and updates on the website. 🔗